DAVID STENEHJEM
Adjunct Associate Professor
Pharmacotherapy
- Adjunct Associate ProfessorPharmacotherapy
RESEARCH INTERESTS
My research expertise is phase I clinical trials in oncology and oncology-related outcomes research to inform personalized health care decision-making. My research focuses on using electronic health record data supporting comparative-effectiveness research and health technology assessment to understand the value of personalized medicine and pharmacotherapy.
GRANTS
- EXTERNAL GRANT OR CONTRACTREAL-WORLD TREATMENT PATTERNS AND CLINICAL OUTCOMES IN METASTATIC PROSTATE CANCER BY HORMONE SENSITIVITY AND HOMOLOGOUS RECOMBINATION REPAIR GENE MUTATIONS9 Jul 2025 - 31 Dec 2026
- EXTERNAL GRANT OR CONTRACTREAL-WORLD MANAGEMENT AND TREATMENT OF DESMOID TUMORS AMONG PATIENTS WITH FAMILIAL ADENOMATOUS POLYPOSIS29 May 2025 - 31 Dec 2027
- EXTERNAL GRANT OR CONTRACTTREATMENT PATTERNS AND OUTCOMES OF PATIENTS WITH METASTATIC PANCREATIC ADENOCARCINOMA29 Jan 2025 - 31 Dec 2026
- EXTERNAL GRANT OR CONTRACTIDENTIFICATION AND CHARACTERIZATION OF PATIENTS WITH DESMOID TUMOR AND THE ASSOCIATED EPIDEMIOLOGY IN THE USSPRINGWORKS THERAPEUTICS17 May 2023 - 30 Jun 2026
- EXTERNAL GRANT OR CONTRACTIDENTIFYING TREATMENT AND TESTING DISPARITIES IN METASTATIC BREAST CANCER TO IMPROVE TREATMENT PATHWAYS AND OUTCOMES.ASTRAZENECA28 Nov 2022 - 30 Jun 2026
- EXTERNAL GRANT OR CONTRACTAZ MESOASTRAZENECA1 Jan 2015 - 31 Dec 2016
- EXTERNAL GRANT OR CONTRACTMYRIAD GENETIC COUNSELINGMYRIAD GENETICS INC1 Jan 2015 - 31 Dec 2017
- EXTERNAL GRANT OR CONTRACTCML EXPANSIONNOVARTIS PHARMACEUTICALS CORP1 Jan 2014 - 31 Dec 2014
- EXTERNAL GRANT OR CONTRACTOVARIAN CANCER WILDTYPE V BRCAASTRAZENECA11 Nov 2013 - 31 Dec 2015